NattoPharma MenaQ7 jog bridge

Menaq7 logo Natto Pharma scienceMenaQ7® is the first, best and only clinically-proven Vitamin K2 as MK-7 for bone and cardiovascular health, and the only patented Vitamin K2 as MK-7 for heart health, meeting the growing demand for high-purity, stable, and well-researched K2 for supplemental and food use. Considered “The Expert Brand,” as it was the source material used by leading researchers to discover and substantiate the benefits of Vitamin K2 as MK-7, MenaQ7® offers a comprehensive product line for manufacturers, including Natural, Soy, Nature-identical Synthetic, and the new Full Spectrum.

  • Organic
  • Non-GMO
  • Kosher
  • GRAS

NattoPharma MenaQ7 Hogne portrait

Guest: Dr. Hogne Vik
A physician by education, Hogne Vik, MD, PhD, MBA, has a long and successful track record in both the pharmaceutical and dietary supplement industries. He currently serves as the Chief Medical Officer with NattoPharma ASA, the world leaders in Vitamin K2 research and development, and exclusive supplier of MenaQ7®, the first and best clinically-validated Vitamin K2 as MK-7 available.

NattoPharma logo



Learn more at:

NattoPharma ASA
Head Office
Lilleakerveien 2B
0283 Oslo, Norway
Tel: (+47) 40 00 90 08

NattoPharma USA
95 Newfield Ave., Suite C
Edison, NJ 08837
Tel: (+1) 609-454-2992

About NattoPharma

NattoPharma, based in Norway, is the world leader in vitamin K2 research and development, and is the exclusive international supplier of MenaQ7® Vitamin K2 as MK-7, the best documented, vitamin K2 as menaquinone-7 (MK-7) with guaranteed actives and stability, clinical substantiation, and international patents granted and pending. The company has a multi-year research and development program to substantiate and discover the health benefits of vitamin K2 for applications in the marketplace for functional food and dietary supplements, and has provided MenaQ7® as the source material for the important studies confirming the benefits of vitamin K2. With a global presence, the company established its North American subsidiary, NattoPharma USA, Inc., in Edison, NJ, and NattoPharma R&D Ltd. in Cyprus.

Share this Project

Leave a Comment